Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EC education

This article was originally published in The Tan Sheet

Executive Summary

Identical bills to establish public education awareness programs on emergency contraception introduced in Senate, House March 6. "Emergency Contraception Education Act" (S 1990) would provide $10 mil. per year for five years for the CDC and Health Resources & Services Administration to develop and disseminate consumer, healthcare professional information describing "use, safety, efficacy and availability" of ECs. Introduced by Sen. Patty Murray (D-Wash.), the bill was referred to the Health & Education Committee. Its twin in the House was introduced by Rep. Louise Slaughter (D-N.Y.); HR 3887 was referred to the Commerce Committee. Bills come one week after Rep. Melissa Hart (R-Penn.) introduced a measure that would bar federal education funding for schools that provide access to ECs; HR 3805 was referred to the Education Committee...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS093722

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel